5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists-Reference-Cited by-同舟云学术

5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists

Published:2003-05 Issue:10 Volume:13 Page:1801-1804
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Koyama Hiroo,Boueres Julia K,Han Wei,Metzger Edward J,Bergman Jeffrey P,Gratale Dominick F,Miller Daniel J,Tolman Richard L,MacNaul Karen L,Berger Joel P,Doebber Thomas W,Leung Kwan,Moller David E,Heck James V,Sahoo Soumya P

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes

2. New drug targets for type 2 diabetes and the metabolic syndrome

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring fingerprints for antidiabetic therapeutics related to peroxisome proliferator-activated receptor gamma (PPARγ) modulators: A chemometric modeling approach;Computational Biology and Chemistry;2024-10

2. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review;Current Topics in Medicinal Chemistry;2024-04

3. Chemistry and Applications of Functionalized 2,4‐Thiazolidinediones;European Journal of Organic Chemistry;2023-05-03

4. H2S- and Redox-State-Mediated PTP1B S-Sulfhydration in Insulin Signaling;International Journal of Molecular Sciences;2023-02-02

5. An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes;Journal of Advanced Research;2020-05